<DOC>
	<DOC>NCT00934050</DOC>
	<brief_summary>The purpose of this study is to evaluate the long-term safety and tolerability of ELND005 beyond the 18 months of treatment in original randomized and blinded clinical trail ELND005-AD201.</brief_summary>
	<brief_title>ELND005 Long-Term Follow-up Study in Subjects With Alzheimer's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<criteria>This study is open only to subjects who have completed the week 78 visit in Study ELND005AD201 while taking their assigned dose of study drug medication. Subject has no new medical contraindications to continued participation in the study.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>